Sotirchos, Vlasios S.
Fujisawa, Sho
Vakiani, Efsevia
Solomon, Stephen B.
Manova-Todorova, Katia O.
Sofocleous, Constantinos T.
Funding for this research was provided by:
National Cancer Institute (R21 CA131763-01A1)
Article History
Received: 21 June 2018
First Online: 4 March 2019
Disclosure
: This study was funded in part by NIH/NCI R21 CA131763-01A1 grant and it was presented at the RSNA annual meeting in Chicago November 28th–December 3rd, 2014. Memorial Sloan Kettering Cancer Center is supported by the grant P30 CA008748 from the National Cancer Institute (NCI). Authors Vlasios S. Sotirchos, Sho Fujisawa, Efsevia Vakiani and Katia O. Manova-Todorova indicated no conflict of interest (COI) disclosures to report. Dr. Stephen B. Solomon has reported the following industry relations and potential COI: Consulting: BTG, Johnson & Johnson, Adgero, Aperture Medical, XACT Robotics, Innoblative. Research Support: GE Healthcare, AngioDynamics, Johnson & Johnson, Elesta. Shareholder: Aspire Bariatrics, Aperture Medical, Johnson & Johnson, Immunomedics. Dr. Constantinos T. Sofocleous has reported the following industry relations and potential COI: Consulting: Neuwave/Ethicon Johnson & Johnson, Terumo Medical, GE Healthcare. Research Support: Neuwave/Ethicon Johnson & Johnson; Angiodynamics, HS Medical, BTG.